Filing Flows › Attovia Therapeutics (ATTO) › Recalls, complaints & regulation
Attovia Therapeutics (ATTO): clinical trials
Attovia Therapeutics (ATTO) beyond its filings: 2 active clinical trials.
Attovia Therapeutics' latest quarter
Attovia Therapeutics, Q2 2026: revenue $450K, net loss $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Attovia Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.